These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33370020)

  • 1. Racial Differences in Gastroenteropancreatic Neuroendocrine Tumor Treatment and Survival in the United States.
    Kessel E; Naparst M; Alpert N; Diaz K; Ahn E; Wolin E; Taioli E; Kim MK
    Pancreas; 2021 Jan; 50(1):29-36. PubMed ID: 33370020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
    Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
    Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
    JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
    Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
    Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Concepts in the Management of GEP-NETs: Introduction.
    Iyer R
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):3-4. PubMed ID: 27167990
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients.
    Baeg K; Harris C; Naparst MS; Ahn E; Thapi S; Martin J; Rustgi S; Mhango G; Wisnivesky J; Kim MK
    BMC Cancer; 2021 Feb; 21(1):146. PubMed ID: 33563241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results-Medicare analysis of 5235 patients.
    Ni K; Yang JY; Baeg K; Leiter AC; Mhango G; Gallagher EJ; Wisnivesky JP; Kim MK
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1387. PubMed ID: 33835729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-Based Differences in Prognosis of Patients With Gastroenteropancreatic-Neuroendocrine Neoplasms: A Population-Based Study.
    Abdel-Rahman O; Fazio N
    Pancreas; 2021 May-Jun 01; 50(5):727-731. PubMed ID: 34016894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.
    Chan DT; Luk AO; So WY; Kong AP; Chow FC; Ma RC; Lo AW
    BMC Endocr Disord; 2016 Feb; 16():12. PubMed ID: 26911576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
    Singal V; Singal AK; Kuo YF
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
    Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
    Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer Among Different Treatment Facility Types.
    Zhu F; Wang H; Ashamalla H
    Pancreas; 2020; 49(10):1355-1363. PubMed ID: 33122525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
    Martin JA; Warner RR; Wisnivesky JP; Kim MK
    Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Patients With Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus.
    Thapi S; Baeg K; Kim MK; Gallagher EJ
    Pancreas; 2021 Oct; 50(9):1293-1297. PubMed ID: 34860814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cases in the Management of GEP-NETs: The Use of Surgery, an Underutilized Option in the Management of Advanced-Stage NETs.
    Boudreaux JP
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):7-11. PubMed ID: 27167992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.